Frontlight ResearchEarly access
Diabetic eye disease trials in Georgia
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
- Where
- Tbilisi
- Age
- 18 years to 80 years
- People
- 21 worldwide
- Run by
- Therini Bio Pty Ltd
See details and how to joinNCT06701721